Given that the miR-10a/ACTG1 regulatory axis may contribute to the enrichment of the ‘Proteoglycans in Cancer’ pathway, it could play a role in cross-species HCC progression. This evidence concerns the gene ACTG1 and hepatocellular carcinoma.